Gain Therapeutics, Inc. (GANX)
1.88
+0.01
(+0.53%)
USD |
NASDAQ |
Apr 14, 14:46
Gain Therapeutics Market Cap : 79.88M for April 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.727B |
| Agenus, Inc. | 169.72M |
| Alnylam Pharmaceuticals, Inc. | 44.50B |
| Savara, Inc. | 1.253B |
| Arrowhead Pharmaceuticals, Inc. | 9.272B |
Market Cap Related Metrics
| Price to Book Value | 4.303 |
| Price | 1.88 |
| Earnings Yield | -32.64% |